The goal of this study was to develop and statistically optimize the metronidazole (MET), chitosan (CS) and alginate (Alg) nanoparticles (NP) nanocomposites (MET-CS-AlgNPs) using a (2¹ × 3¹ × 2¹) × 3 = 36 full factorial design (FFD) to investigate the effect of chitosan and alginate polymer concentrations and calcium chloride (CaCl₂) concentration ondrug loading efficiency(LE), particle size and zeta potential. The concentration of CS, Alg and CaCl₂ were taken as independent variables, while drug loading, particle size and zeta potential were taken as dependent variables. The study showed that the loading efficiency and particle size depend on the CS, Alg and CaCl₂ concentrations, whereas zeta potential depends only on the Alg and CaCl₂ concentrations. The MET-CS-AlgNPs nanocomposites were characterized by X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), thermal gravimetric analysis (TGA), scanning electron microscopy (SEM) and in vitro drug release studies. XRD datashowed that the crystalline properties of MET changed to an amorphous-like pattern when the nanocomposites were formed.The XRD pattern of MET-CS-AlgNPs showed reflections at 2θ = 14.2° and 22.1°, indicating that the formation of the nanocompositesprepared at the optimum conditions havea mean diameter of (165±20) nm, with a MET loading of (46.0 ± 2.1)% and a zeta potential of (−9.2 ± 0.5) mV.The FTIR data of MET-CS-AlgNPs showed some bands of MET, such as 3283, 1585 and 1413 cm⁻¹, confirming the presence of the drug in the MET-CS-AlgNPs nanocomposites. The TGA for the optimized sample of MET-CS-AlgNPs showed a 70.2% weight loss compared to 55.3% for CS-AlgNPs, and the difference is due to the incorporation of MET in the CS-AlgNPs for the formation of MET-CS-AlgNPs nanocomposites. The release of MET from the nanocomposite showed sustained-release properties, indicating the presence of an interaction between MET and the polymer. The nanocomposite shows a smooth surface and spherical shape. The release profile of MET from its MET-CS-AlgNPs nanocomposites was found to be governed by the second kinetic model (R² between 0.956–0.990) with more than 90% release during the first 50 h, which suggests that the release of the MET drug can be extended or prolonged via the nanocomposite formulation.

Quinazoline, a privileged scaffold in medicinal chemistry, offers promising potential in the synthesis of anti-Alzheimer’s disease (AD) drugs. This heterocyclic compound, characterized by its fused benzene and pyrimidine rings, enables the design of multifunctional agents targeting AD pathology. The drug-like aspects and pharmaceutical features of quinazoline derivatives have the potential to give rise to various therapeutic drugs. AD is a progressive neurodegenerative condition marked by memory decline, cognitive deterioration, and language disorders. Given its complexity and multifaceted nature, there is a pressing need to discover multi-target drugs to effectively address this debilitating disorder. A comprehensive literature review has demonstrated that quinazoline derivatives exhibit a wide range of therapeutic potential for AD. These compounds function as inhibitors of cholinesterases, β-amyloid aggregation, oxidative stress, and tau protein, among other protective effects. Here, we highlight the most significant and recent research on quinazoline-based anti-AD agents, aiming to support the development and discovery of novel treatments for AD.

The purpose of this study was to investigate the effect of chitosan (CS) and Alginate (Alg) polymers concentrations and CaCl2 concentration on metronidazole (MET) drug loading (LE), size particles and zeta potential. Nanocomposites were prepared by ionotropic pregelation method. A (21 *31 *21) *3= 36 full factorial design (FFD) was used to predict statistical equation and responses. The MET-CS-AlgNPs nanocomposites were characterized by X-ray diffraction, Fourier-transform infrared spectroscopy, thermal gravimetric analysis, scanning electron microscope and in vitro drug release studies. All data indicated the presence of drug into MET-CS-AlgNPs nanocomposites. The release profile of MET-CS-AlgNPs nanocomposites was found to be sustained

Macroscopic and microscopic analysis of R. damascena buds and flower petals was used to find the main morphological and anatomical features of these types of medicinal plant material (MPM). The presence of polysaccharides, free and bound monosaccharides, tannins, flavonoids, saponins, and essential oils was confirmed by chemical and histochemical reactions. The quality indicator of R. damascena buds and flower petals was evaluated in this study; weight loss on drying gave the next result: 6.690.20 for flower petals and 6.650.13 for buds. The swelling index showed a high result for R. damascena flower petals and buds. R. damascena buds swelling index50.2 and R. damascenaflower petals swelling index150.6. The determination of volatile substances by GC/MS shows the presence of 18 volatile compounds in flower petals and buds, this number varies up to 17. Nonadecane, heneicosane, and octadecane are the main components in both medicinal plant materials. Both buds and flower petals contain approximately the same amount of citronellol. Phenylethyl alcohol is present in large amounts in buds but in small amounts in flower petals. R. damascena flower petals and buds are the sources of volatile compounds, phenols, and polysaccharides. The results of our investigation showed great differences and similarities between buds and flower petals of R. damascena. We have confirmed that not only buds but also flower petals could be a source of biologically active substances (BASs) such as essential oils, polysaccharides, and phenolic compounds. Flower petals could be an alternative MPM. We would also like to underline the importance of standard documentation for MPM: its macro and microscopic description, harvest time, control techniques of the qualitative composition, and the quantitative content of the main BAS. Because it will help in the production of various high-quality products that can be used in medicine, pharmacy, food, and the perfume industries.

The technological parameters and quality indicators of corn silk were evaluated in this study: specific density, volumetric density, bulk density, porosity, spatial layer, free volume of the layer, the absorption coefficient, weight loss on drying, and extractives. The technology for obtaining a liquid extract of corn silk was developed. The most effective extractant was discovered to be 40% ethanol, with an extraction time of 120 minutes. The qualitative composition and quantitative content of the major groups of biologically active substances (BAS) in the obtained liquid extract were determined. The qualitative composition of the main groups of BAS was determined by conventional chemical reactions. This extract contained free reduced sugars, glycosides (bound reduced sugars), phenols, tannins, flavonoids, saponins, and hydroxycinnamic acids. The quantitative content of phenolic compounds was performed by UV-vis-spectrophotometry. Total phenols, tannins, flavonoids, and hydroxycinnamic acids had quantitative contents of 8.25 ± 0.33%, 1.4 ± 0.03%, 2.20 ± 0.06%, 3.30 ± 0.13%, respectively. The acute toxicity study was carried out with a single intragastric administration to outbred unanesthetized white rats of both sexes. Duration of observation of animals was 14 days. It was revealed that corn silk extract at doses of up to 5.0 ml/kg is safe. A single injection of a liquid extract has no effect on internal organs when compared to a control group. Corn silk liquid extract’s hemostatic efficacy was assessed using blood clotting time, prothrombin time, and blood clot retraction index. The corn silk liquid extract reduces blood coagulation time, decreases prothrombin time, and increases the blood clot retraction index. According to these findings, corn silk liquid extract is rich in phytochemicals and possesses a potential therapeutic effect on bleeding disorders. Furthermore, it could be used in the pharmaceutical sciences industry to develop medicines for testing in the treatment of various diseases.

Evaluation of the Wheat Germ Oil Topical Formulations for Wound Healing Activity in Rats